These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19672027)

  • 21. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris.
    Cosin-Sales J; Christiansen M; Kaminski P; Oxvig C; Overgaard MT; Cole D; Holt DW; Kaski JC
    Circulation; 2004 Apr; 109(14):1724-8. PubMed ID: 15023879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations.
    Braun S; Ndrepepa G; von Beckerath N; Vogt W; Schömig A; Kastrati A
    Atherosclerosis; 2004 May; 174(1):105-10. PubMed ID: 15135258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole blood viscosity in microvascular angina and coronary artery disease: Significance and utility.
    Cekirdekci EI; Bugan B
    Rev Port Cardiol (Engl Ed); 2020 Jan; 39(1):17-23. PubMed ID: 32156449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation.
    Akboga MK; Canpolat U; Sahinarslan A; Alsancak Y; Nurkoc S; Aras D; Aydogdu S; Abaci A
    Atherosclerosis; 2015 May; 240(1):110-4. PubMed ID: 25770689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris.
    Cosin-Sales J; Kaski JC; Christiansen M; Kaminski P; Oxvig C; Overgaard MT; Cole D; Holt DW
    Eur Heart J; 2005 Oct; 26(20):2093-8. PubMed ID: 16055491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease.
    Mathiasen AB; Harutyunyan MJ; Jørgensen E; Helqvist S; Ripa R; Gøtze JP; Johansen JS; Kastrup J
    Scand J Clin Lab Invest; 2011 Sep; 71(5):439-47. PubMed ID: 21827355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of serum cysteine-rich protein 61 levels in patients with coronary artery disease.
    Deng J; Qian X; Li J; Li Y; Li Y; Luo Y
    Biomark Med; 2018 Apr; 12(4):329-339. PubMed ID: 29345157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic inflammatory status in patients with coronary artery ectasia.
    Li JJ; Nie SP; Qian XW; Zeng HS; Zhang CY
    Cytokine; 2009 Apr; 46(1):61-4. PubMed ID: 19232498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of concentrations of high-sensitivity troponin T and high-sensitivity C-reactive protein with plaque progression as measured by CT coronary angiography.
    Seifarth H; Schlett CL; Lehman SJ; Bamberg F; Donnelly P; Januzzi JL; Koenig W; Truong QA; Hoffmann U
    J Cardiovasc Comput Tomogr; 2014; 8(6):452-8. PubMed ID: 25467832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma Soluble Endoglin Levels Are Inversely Associated With the Severity of Coronary Atherosclerosis-Brief Report.
    Saita E; Miura K; Suzuki-Sugihara N; Miyata K; Ikemura N; Ohmori R; Ikegami Y; Kishimoto Y; Kondo K; Momiyama Y
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):49-52. PubMed ID: 27789477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased plasma C-reactive protein level predicts rapid progression of non-target atherosclerotic lesions in patients with stable angina after stenting.
    Xu YL; Li JJ; Xu B; Zhu CG; Yang YJ; Chen JL; Qiao SB; Yuan JQ; Qin XW; Ma WH; Yao M; Liu HB; Wu YJ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2011 Oct; 124(19):3022-9. PubMed ID: 22040548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability.
    Soeki T; Niki T; Kusunose K; Bando S; Hirata Y; Tomita N; Yamaguchi K; Koshiba K; Yagi S; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Akaike M; Sata M
    J Cardiol; 2011 Sep; 58(2):151-7. PubMed ID: 21676590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes.
    Bayes-Genis A; Conover CA; Overgaard MT; Bailey KR; Christiansen M; Holmes DR; Virmani R; Oxvig C; Schwartz RS
    N Engl J Med; 2001 Oct; 345(14):1022-9. PubMed ID: 11586954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary vasomotor response is related to the angiographic extent of coronary sclerosis in patients with stable angina pectoris.
    Asselbergs FW; Monnink SH; Veeger NJ; van Boven AJ; van Haelst PL; Jessurun GA; van Gilst WH; Tio RA
    Clin Sci (Lond); 2004 Feb; 106(2):115-20. PubMed ID: 12956627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is galectin-3 a biomarker, a player-or both-in the presence of coronary atherosclerosis?
    Aksan G; Gedikli Ö; Keskin K; Nar G; İnci S; Yıldız SS; Kaplan Ö; Soylu K; Kılıçkesmez KO; Şahin M
    J Investig Med; 2016 Mar; 64(3):764-70. PubMed ID: 26912009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intracoronary temperature in patients with coronary artery disease].
    Shindo N; Tanaka N; Kobori Y; Kobayashi H; Teramoto T; Takazawa K; Yamashina A
    J Cardiol; 2005 May; 45(5):185-91. PubMed ID: 15929386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.
    Koga S; Ikeda S; Yoshida T; Nakata T; Takeno M; Masuda N; Koide Y; Kawano H; Maemura K
    JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
    Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of clinical characteristics and prognosis in Taiwanese patients with coronary vasospastic angina pectoris without significant fixed coronary artery disease versus patients with significant fixed coronary artery disease and either stable angina pectoris or acute coronary syndromes.
    Hung MJ; Hung MY; Cheng CW; Yang NI; Cherng WJ
    Am J Med Sci; 2007 Sep; 334(3):160-7. PubMed ID: 17873528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.